Validation Changes to the USP Assay Method for Ibuprofen Tablets
News
Article
Pharmaceutical TechnologyPharmaceutical Technology-03-02-2002
Volume 26
Issue 3
This study investigated the effectiveness of the direct extraction of tablets and shaking time on the disintegration of tablets, solubilization, and recovery of ibuprofen from tablets of various formulations, strengths, and spiked placebo.
Articles in this issue
Outsourcing Outlook
Developing Custom Adhesive Systems for Transdermal Drug Delivery
Overview of Technologies Supporting Security Requirements in 21 CFR Part 11, Part II
PDA Task Force Issues Guidelines to Aid Isolator Users
Recent Advances in Semisolid Dosage Forms for Dermatological Application
Drug Safety Concerns Shape Manufacturing Policy
Production Information Mangement
Functionality Testing of a Multifunctional Directly Compressible Adjuvant Containing Lactose, Polyvinylpyrrolidone, and Croscarmellose Sodium
Public CROs Craft New Strategies to Achieve Financial and Strategic Objectives
Validation Changes to the USP Assay Method for Ibuprofen Tablets
Systematic Troubleshooting for LC/MS/MS
Product Development Issues of Powders for Injection
Oral Low Molecular Weight Heparin Absorption From Solution and Solid Dosage Forms in Rat, Dog, and Monkey Models
Pharmaceutical Reserch and Manufacturers Association Acceptable Analytical Practice for Analytical Method Transfer
Recent Videos
A CDMO’s Role in API Quality
Ask the Expert: Quality Control Units
Industry Outlook 2025: European Geopolitical Impact on Pharma
Industry Outlook 2025: Political Implications for Pharma
Ask the Expert: EU Data Protection
Industry Outlook 2025: The Impact of Politics on Pharma
Industry Outlook 2025: Technology as a Supporting Element
Tariff Pause Reinforces Uncertainty Among Biopharma Professionals
Industry Outlook 2025: Talent Up for Grabs
INTERPHEX 2025: ‘Breaking Up the Octopus’ of Single-Use Systems
Related Content
Guidance on Quality Culture Standards
June 3rd 2025Article
Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.
